Advances in Hematology and Oncology

Publish date: September 3, 2021

 

Advances in Hematology and Oncology

  • Integrated Care for Cancer-Related Distress
  • Solid Tumor Checkpoint Inhibitor Dosing Models and Toxicity
  • Evidence-Based Algorithm for Prostate Cancer Bone Health
  • QOL and Toxicity After High-Dose Brachytherapy for Prostate Cancer
  • An Interdisciplinary Approach to Comorbid Pancreatic Cancer and Substance Use Disorder
  • Three Primary Cancers in a Veteran With Toxic Exposures

Recommended Reading

Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate Cancer
AVAHO
Polygenic breast cancer risk scores strive to overcome racial bias
AVAHO
COVID booster may benefit active-treatment cancer patients
AVAHO
Use and Toxicity of Checkpoint Inhibitors for Solid Tumor Treatment in a Veteran Population
AVAHO
Better to binge drink than regularly tipple, suggests GI cancer study
AVAHO
Oncologists’ income and net worth rise despite pandemic
AVAHO
FDA warns clinicians to stop using Eco-Med products because of contamination concerns
AVAHO
Pandemic-related drops in breast cancer screening hit hardest among medically underserved
AVAHO
Although inconclusive, CV safety study of cancer therapy attracts attention
AVAHO
Antiviral Therapy Improves Hepatocellular Cancer Survival
AVAHO